Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2019 third-quarter earnings
Johnson & Johnson Q3 2019 Earnings

What you need to know about Johnson & Johnson’s 2019 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Inset - Quarterly Earnings Ribbon

This morning, Johnson & Johnson shared its third-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“We delivered strong revenue and earnings growth during the third quarter, while also making strategic investments that advance our innovative pipeline across all three business segments,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our colleagues around the world are passionate and committed to driving robust performance, while providing healthcare solutions that deliver long-term value to our patients, consumers, employees, communities and shareholders.”

For more details about the company’s 2019 third-quarter results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


UPDATED Johnson & Johnson Q3 2019 Earnings infographic

Johnson & Johnson’s 2019 3rd-Quarter Earnings

Read the earnings press release, which includes full financial details for the third quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

More from Johnson & Johnson

What are cataracts?

If you can’t read a screen without jacking up the brightness level or if night driving leaves you seeing fuzzy halos around traffic lights, you may among the 20 million U.S. adults who develops a cataract—the most common cause of vision loss worldwide. Luckily a simple surgical procedure can have you viewing the world in crisp, bright color again. Here’s what to know about cataract symptoms and removal.

Meet two brothers who are revolutionizing the way scientists develop treatments for cancer

Justin and Colin Farlow share how their next-generation cell and gene therapies are helping Johnson & Johnson in its quest to get in front of cancer.

By the numbers: Understanding dry eye disease

For National Dry Eye Awareness Month, learn about the causes of this common condition and how Johnson & Johnson is helping to find treatment options.